NCT05492682 2026-05-12START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of CancerValo Therapeutics OyPhase 1 Recruiting15 enrolled
NCT06083883 2026-04-16Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1M.D. Anderson Cancer CenterPhase 1 Recruiting44 enrolled